About US
Contact us
-
InSite Vision to Advance New Ocular Anti-Inflammatory CandidateInSite Vision Incorporated, a company developing ophthalmic products for unmet eye care needs, recently announced plans to advance new development candidate ISV-303, a topical anti-inflammator2009/12/29
-
Isis Pharmaceuticals to Receive $10 Million From OncoGenex’s License of OGX-011 to TevaIsis Pharmaceuticals, Inc. recently announced that it will receive a $10-million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex's license of OGX-011 to Teva Pharmaceutic2009/12/29
-
Makefield Therapeutics Licenses Patent Rights Covering Its Hybrid Nanoparticle Delivery PlatformMakefield Therapeutics, Inc., an emerging therapeutics company, recently announced it has obtained an exclusive license from Albert Einstein College of Medicine of Yeshiva University to patent applica2009/12/29
-
IPEC-AMERICAS NEWSSOURCE: WEB OF IPECIPEC American news20091228(2).rar2009/12/28
-
PSWC & AAPS - 2010 eventPSWC & AAPS - Improving Global Health Through Advances in Pharmaceutical Sciences Gattefossé continues its support for the AAPS and we are delighted to be part of the exciting 2010 eve2009/12/28
-
SFDA：Provisions for Drug Advertisement ExaminationSFDA：Provisions for Drug Advertisement Examination (SFDA Decree No. 27)The Provisions for Drug Advertisement Examination, adopted by the State Food and Drug Administration and2009/12/28
-
PTC Therapeutics Closes $50-Million FinancingPTC Therapeutics, Inc. recently announced the completion of a $50-million financing. The round was led by The Column Group (a new investor) and existing investor Delphi Ventures. The co-lead invest2009/12/25
-
ISP Pharmaceuticals to Participate in the World DrugWayne, N.J. – December 10, 2009:Wayne, New Jersey (December 15, 2009) - ISP, a major supplier of ingredients and services for solubility and bioavailability enhancement will participate in the2009/12/25
-
Name change for Elastogran companies· Elastogran to become BASF Polyurethanes · Reinforcing leadership in systems and specialties · Existing legal agreements not affected Ludwigshafen , Germany – December 22, 2009 – Following the2009/12/25
-
Drug regulatory and postal departments of China jointly guard against selling counterfeit drugs through postal and express deliveryThe State Post Bureau and the State Food and Drug Administration (SFDA) of China recently jointly issued a notice, which requires postal regulatory departments and drug regulatory department2009/12/24